WO2014187576A1

WO2014187576A1 - Deodorizing active ingredient combination

Info

Publication number: WO2014187576A1
Application number: PCT/EP2014/052046
Authority: WO
Inventors: Thomas Döring; Rainer Simmering
Original assignee: Henkel Ag & Co. Kgaa
Priority date: 2013-05-22
Filing date: 2014-02-03
Publication date: 2014-11-27
Also published as: DE102013209460A1

Abstract

The invention relates to cosmetic agents containing: a) between 0.1 and 1.0 wt. % of at least one non-ionic bactericide A having a boiling point above 120°C; b) between 0.1 and 1.0 wt. % of at least one perfume ester B. Said agents are characterised by an unexpectedly long-lasting deodorizing action.

Description

"Deodorizing drug combination"

The present application relates to cosmetic and dermatological antiperspirant and deodorant compositions which have an improved effect.

Commercially available antiperspirant compositions, hereinafter also referred to as antiperspirants, contain as antiperspirant active ingredient at least one water-soluble astringent inorganic and organic salts of aluminum, zinc or selected aluminum-zirconium mixed salts. Commercially available deodorant compositions, also referred to below as deodorants, frequently contain at least one antibacterial active substance as the deodorant active ingredient.

The antiperspirant active ingredients have no direct influence on the activity of the sweat glands, but minimize the narrowing of the discharge channels sweat secretion. The AI salts cause thereby on the treated skin surfaces a sweat inhibition by superficial blockage of the sweat gland ducts as a result of Al-Mucopolysaccharid precipitation.

Antiperspirant and deodorant compositions are usually applied and applied in the forearm region or in the region of the armpits. The skin in this area is usually more sensitive than the rest of the body's skin, often at least as sensitive as the skin on the face. There is therefore a constant need for particularly skin-compatible formulations which are suitable as carriers for cosmetic and dermatological antiperspirant and deodorant compositions. Furthermore, there is a need for particularly skin-friendly formulations which, as carriers for cosmetic and dermatological antiperspirant and deodorant compositions, may be able to make the antiperspirant and deodorant active ingredients that sometimes irritate the skin and make them more irritable to the skin or to reduce their irritative effect ,

The object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions with particularly high skin tolerance. A further object of the present invention was to find active substances and / or carriers for cosmetic and dermatological antiperspirant and deodorant compositions which effectively and specifically combat the odor-causing bacteria without causing damage to the skin-positive bacteria in the skin flora and, moreover, a have long-lasting deodorizing effect.

It has now been found that a combination of a specific bactericide and a fragrance ester is not only excellent for incorporation in antiperspirant and deodorant Compositions suitable and specifically fights the odor causing bacteria but also has an unexpectedly long deodorizing effect. A first subject of the present application is a cosmetic agent containing in a cosmetically acceptable carrier

a) 0.1 to 1, 0 wt .-% of at least one nonionic bactericidal A having a boiling point above 120 ° C;

b) 0.1 to 1, 0 wt .-% of at least one fragrance ester B.

The agents according to the invention contain as the first essential constituent a nonionic bactericide A having a boiling point above 120.degree. Preferably, the boiling point of the nonionic bactericide A is more than 150 ° C, preferably more than 180 ° C and especially more than 210 ° C. The proportion by weight of the bactericide A in the total weight of the cosmetic agent is preferably 0.2 to 0.9% by weight, preferably 0.3 to 0.8% by weight and in particular 0.4 to 0.7% by weight of bactericide A contains. In a preferred embodiment, the cosmetics according to the invention contain at least one bactericide from the group chlorhexidine, farnesol, trichlosan, chlorxylenol and phenoxyethanol. Particularly preferred is the use of phenoxyethanol.

As a second essential component, the cosmetic compositions according to the invention contain at least one perfume ester B. The proportion by weight of the perfume ester B in the total weight of the cosmetic agent is preferably 0.1 to 0.8% by weight, preferably 0.2 to 0.6% by weight. % and in particular 0.3 to 0.5% by weight of perfume ester B. Preferred perfume esters come from group 3a, 4,5,6,7,7a-hexahydro-4,7-methano-1H-indenyl acetate, tricyclo [5.2 .1.02,6] dec-4-en-8-yl acetate, 3a, 4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate, 2-tert-butylcyclohexyl acetate, cis -2-tert-butylcyclohexylacetate, trans-2-tert-butylcyclohexylacetate, 4-tert-butylcyclohexylacetate, cis-4-tert-butylcyclohexylacetate, trans-4-tert-butylcyclohexylacetate, 3a, 4,5,6,7,7a-hexahydro 4,7-methano-1H-indenyl propionate, 3a, 4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl propionate, 3a, 4, 5, 6 , 7,7-hexahydro-4,7-methano-1H-inden-5-yl propionate, benzyl salicylate, cyclohexyl salicylate, pentyl salicylate, 2-methylbutylsa licylate, isopentyl salicylate, exo-1, 7,7-trimethylbicyclo [2.2.1] hept-2-yl acetate, p-menth-1-en-8-yl acetate, terpineol acetate, benzyl acetate, hexyl salicylate, alpha, alpha-dimethylphenethylacetate, 1-phenylethyl acetate, linalyl acetate, phenethyl acetate, hexyl acetate, citronellyl acetate, geranyl acetate, neryl acetate, citronellyl acetate, p-menthane-8-yl acetate, alpha, alpha-4-trimethylcyclohexylmethyl acetate, nopyl acetate, ethylacetoacetate, 3-methyl-2-butenyl acetate, 2-cyclohexylethyl acetate, isononyl acetate, isobutyl salicylate, [3R- (3.alpha., 3a.beta., 7.beta., 8a.alpha.)] - 2,3,4,7,8,8a-hexahydroxyacetate. 3,8,8-trimethyl-1H-3a, 7-methanoazulenes-6-methylacetate, phenethylphenylacetate, (Z) -3-hexenylsalicylate, (Z) -hex-3-enylacetate, 1, 3-dimethyl-3 phenylbutyl acetate, methyl salicylate, isopentyl acetate, neryl acetate, cinnamyl acetate, menthyl acetate, 1, 2,3,3a, 4,5,6,8a-octahydro-2-isopropylidenes-4,8-dimethylazulen-6-yl acetate, allylphenoxyacetate, decahydro-2-naphthylacetate, myrcenylacetate, methylphenylacetate, ethylsalicylate, 3 (or 4) - (4-methylpenten-3-yl) cyclohex-3-ene-1-methylacetate, 1-methyl-1 - (3S , 8S) - 1, 2,3,4,5,6J, 8-octahydro-3,8-dimethy) azuten-5-yl) ethyl acetate, ethyl acetate, phenyl salicylate, phenethyl salicylate, p-tolyl acetate, p-tolylphenyl acetate and / or 1, 1, 5-trimethylhepta-4,6-dienyl acetate. The use of menthyl acetate as fragrance ester B is particularly preferred. In addition to the pure menthyl acetate, it is also possible to add menthyl acetate-containing compositions to the compositions according to the invention. A preferred source of menthyl acetate is peppermint oil.

For the deodorizing effect of the cosmetic compositions according to the invention, it has proved to be particularly advantageous to use the bactericide A and the perfume ester B in specific weight ratios. Preferred cosmetic agents according to the invention are therefore characterized in that the weight ratio of bactericide A to perfume ester B is 10: 1 to 1:10, preferably 6: 1 to 1: 6 and in particular 4: 1 to 1: 4. Active substance combinations of phenoxyethanol and menthyl acetate have proven to be particularly effective with respect to their deodorizing action. In a particularly preferred embodiment, the cosmetic compositions according to the invention therefore contain phenoxyethanol and menthyl acetate in a weight ratio of 10: 1 to 1:10, preferably 6: 1 to 1: 6 and in particular 4: 1 to 1: 4.

Antiperspirant active ingredient

Cosmetic compositions according to the invention which are present as antiperspirant antiperspirant contain as antiperspirant active ingredient at least one antiperspirant aluminum salt in a total amount of 2-40% by weight, preferably 10-35% by weight, particularly preferably 1-12% by weight. and most preferably 12-20% by weight, the weight percentages being based on the total weight of the water-free and ligand-free active substance (USP) in the composition, without taking account of any propellant present.

The antiperspirant aluminum salts are preferably selected from the water-soluble astringent inorganic and organic salts of aluminum and aluminum-zirconium mixtures. According to the invention, aluminosilicates and zeolites do not belong to the antiperspirant active compounds. According to the invention, water solubility is understood as meaning a solubility of at least 3% by weight at 20 ° C., that is to say amounts of at least 3 g of the antiperspirant active are soluble in 97 g of water at 20 ° C.

Particularly preferred antiperspirant actives are selected from aluminum chlorohydrate, aluminum chlorohydrate, in particular having the general formula [Al ₂ (OH) ₅ CI ^■ 1 -6 H ₂ 0] _n, [AI preferably ₂ (OH) ₅ CI 2-3 ^■ H ₂ 0 ] _n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al ₂ (OH) ₄ Cl ₂ ^■ 1-6 H ₂ 0] _n , preferably [Al ₂ (OH) ₄ Cl ₂ ^■ 2-3 H ₂ O] _n , which may be in unactivated or activated (depolymerized) form.

Also preferred are aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g. Aluminum or aluminum zirconium propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG dichlorohydrex or aluminum PEG dichlorohydrex, aluminum hydroxide further selected from the aluminum zirconium chlorohydrates such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, zirconiumoctachlorhydrexglycin the aluminum zirconium chlorohydrate glycine complexes, such as Aluminiumzirconiumtrichlorhydrexglycin, Aluminiumzirconiumtetrachlorhydrexglycin, Aluminiumzirconiumpentachlorhydrexglycin, aluminum, aluminum potassium sulfate (KAI (S0 ₄₎ ₂ ^■ 12 H ₂ 0, alum), Aluminiumunde- cylenoylcollagenaminosäure, xylactat Natriumaluminiumlactat + aluminum sulfate, Natriumaluminiumchlorhydro-, Aluminum bromohydrate, aluminum chloride, the complexes of zinc and sodium salts, the aluminum salts of lipoamino acids, aluminum sulfate, aluminum lactate, aluminum chloro rhydroxyallantoinate and sodium aluminum chlorhydroxylactate.

Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.

Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, β-alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, β-amino-n-butanoic acid and γ-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred. Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.

Further preferred activated aluminum salts are those of the general formula Al ₂ (OH) ₆ . _a Xa, wherein X is Cl, Br, I or N0 ₃ and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2, 1: 1. These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt. Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a" is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1 ,

Preferred activated aluminum-zirconium salts are those which contain mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) ₂ . _pb Y _b , where Y is Cl, Br, I, NO ₃ or SO ₄ , b is a rational number from 0.8 to 2 and p is the valence of Y, as disclosed, for example, in US 6074632. The zirconium salts usually have as well some water of hydration associatively bound, typically 1 to 7 moles of water per mole of salt. Preferably, the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) ₂ _-b Cl _b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9. Preferred aluminum-zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 1.2, preferably 0.9 to 1.5. A particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1. The term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms. The antiperspirant aluminum salts can be present in both dissolved and solubilized, as well as in undissolved, suspended form.

If the antiperspirant active ingredients in a water-immiscible carrier, in particular in at least one liquid under normal conditions cosmetic oil, suspended and undissolved, it is preferred for reasons of product stability that their particles have a number average particle size of 0.1 - 200 μιη, preferably 1-150 μιη, more preferably 3-100 μιη and exceptionally preferably 5-80 μιη have. Further preferred antiperspirant active ingredient particles have a volume-average particle size of 0.2 to 220 μm, preferably 3 to 160 μm, more preferably 4 to 125 μm, more preferably 5 to 120 μm, and most preferably 10 to 80 μm.

Preferred antiperspirant aluminum-zirconium salts have a molar metal to chloride ratio of 0.9-1.5, preferably 0.9-1.3, more preferably 0.9-1.1. Zirconium-free aluminum salts which are particularly preferred according to the invention have a molar metal-to-chloride ratio of 1.9 to 2.1. Zirconium-free aluminum sesquichlorohydrates which are particularly preferred according to the invention have a molar metal-to-chloride ratio of 1.5: 1-1.8: 1. Preferred aluminum zirconium chlorohydrates generally have the empirical formula Al _n Zr (OH) _[ 3 _{n + 4} . _m ( _{n +} i _)] (CI) _[m (n ₊ i) _] where n = 2.0-10.0, preferably 3.0-8.0, m = 0.77-1.1 (corresponding to a molar metal (Al + Zr) to chloride ratio of 1.3 to 0.9), preferably m = 0.91 to 1.1.1 (corresponding to M: CI = 1.1 to 0.9), and particularly preferably m = 1.00-1.1 (corresponding to M: CI = 1.0-0.9), furthermore very preferably m = 1.02-1.1 (corresponding to M: CI = 0.98 - 0.9), and more preferably m = 1, 04-1, 11 (corresponding to M: CI = 0.96-0.9). In general, some of the water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.

Usually, the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture. Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, β-alanine, cysteine, Valine, serine, tryptophan, phenylalanine, methionine, β-amino-n-butanoic acid and γ-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred. The amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium. Preferred antiperspirant salts are aluminum-zirconium tetrachlorohydrates (Al: Zr = 2-6, M: CI = 0.9-1.3), in particular salts with a molar metal-to-chloride ratio of 0.9-1.1, preferably 0.9 - 1, 0.

Further, according to the invention preferably Aluminiumzirconiumchlorohydrat-glycine salts with betaine ((CH ₃₎ ₃ N ⁺ CI-l2-COO ^") are stabilized. Particularly preferred corresponding compounds have a molar overall (Betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine to glycine molar ratio of at least 0.001: 1.

Preferred cosmetic agents according to the invention are characterized in that these agents furthermore contain at least one antiperspirant active ingredient c), preferably an antiperspirant active ingredient c) from the group of water-soluble astringent inorganic and organic salts of aluminum and zinc, in particular from the group of activated aluminum salts.

Particularly preferred cosmetic agents according to the invention are characterized in that the cosmetic agent, based on its total weight, contains 5 to 50% by weight, preferably 10 to 30% by weight and in particular 15 to 25% by weight of the antiperspirant active substance c) , wherein the wt .-% - information on the total weight of the water-free and ligand-free active substance (USP) in the composition relate, without taking into account any existing propellant.

Compositions according to the invention which are present as a deodorant contain at least one deodorant active ingredient in a total amount of 0.5-40% by weight, preferably 0.8-20% by weight, particularly preferably 1-15% by weight, extraordinarily preferably 1, 5 - 5 wt .-%, wherein the% by weight data refer to the total weight of the composition, without taking into account any existing propellant.

According to the invention, ethanol does not count as a deodorant active ingredient, but, if present, only as a constituent of the carrier.

In a preferred embodiment, the agents according to the invention contain as deodorising agent at least one silver salt, which is preferably selected from silver sulfate, silver nitrate, silver citrate, silver dihydrogen citrate, silver lactate, silver acetate, silver malate, silver succinate, silver tartrate, Silver mandelate, silver salicylate, silver gluconate, silver adipate and silver bergaractarate, as well as mixtures of these salts. Highly preferred are silver sulfate, silver citrate, silver dihydrogen citrate and silver lactate, as well as mixtures of these salts.

Further preferred compositions according to the invention contain at least one silver salt, which is preferably selected from silver sulfate, silver nitrate, silver citrate, silver dihydrogen citrate, silver lactate, silver acetate, silver malate, silver succinate, silver tartrate, silver mandelate, silver salicylate, silver gluconate, silver adipate and silver bergaractarate, as well as mixtures of these salts Amounts that silver in a total amount of 1 - 100 ppm, preferably 2 - 50 ppm, more preferably 5 - 20 ppm, most preferably 7 - 10 ppm, each based on the weight of the propellant-free composition is included. Based on the molecular weights of silver (107.87 g / mol) and the respective silver salts - silver lactate z. B. has a molecular weight of 196.94 g / mol - can be calculated according to the required amount of silver salt (s).

In a further preferred embodiment, the agents according to the invention contain as deodorant active ingredient at least one aromatic alcohol of the structure (AA-1),

R ⁵ R ³ R ¹ (- O -) - ("C -) - (c) - (- C -) - OH

m ⁰ p

R ⁶ R ⁴ R ²

_R 7-1 1

(AA-1)

in which

the radicals R to R ⁶ independently of one another represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and substituted with OH groups or alkoxy groups having 1 to 5 carbon atoms,

the radicals R ⁷ to R independently of one another are a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular with a methoxy group,

m = 0 or 1, n, o, p = are independently integers from 0 to 10, with at least one of the values n, o, p Φ 0.

Particularly preferred cosmetic agents according to the invention comprise at least one alcohol AA-1, as described above, which is selected from anisalcohol, 2-methyl-5-phenylpentan-1-ol, 1,1-dimethyl-3-phenylpropan-1-ol, benzyl alcohol, 2-phenylethane-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1 ol, 2,2-dimethyl-3-phenylpropan-1-ol, 2,2-dimethyl-3- (3'-methylphenyl) propan-1-ol, 2-ethyl-3-phenylpropan-1-ol, 2 -Ethyl-3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (2'-chlorophenyl) -2-ethyl-propan-1 ol, 3- (4'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (3 ', 4'-dichlorophenyl) -2-ethyl-propan-1-ol, 2-ethyl-3- (2'-methyl-phenyl ) -propan-1-ol, 2-ethyl-3- (4'-methylphenyl) -propan-1-ol, 3- (3 ', 4'-dimethylphenyl) -2-ethyl-propan-1-ol, 2 Ethyl 3- (4'-methoxyphenyl) -propan-1-ol, 3- (3 ', 4'-dimethoxyphenyl) -2-ethyl-propan-1-ol, 2-allyl-3-phenylpropan-1-ol and 2-n-pentyl-3-phenylpropan-1-ol and mixtures thereof. Further particularly preferred compositions according to the invention comprise at least one alcohol AA-1, as described above, in a total amount of 0.05-10% by weight, preferably 0.1-1.5% by weight, more preferably 0.2-2% by weight .-%, most preferably 0.3 to 1, 5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.

In a further preferred embodiment, the agents according to the invention contain as deodorant active ingredient at least one 1,2-alkanediol having 5 to 12 C atoms, which is described by the formula HO-CH ₂ -CH (OH) - (CH ₂ ) n-CH ₃ in which n stands for the numbers 2, 3, 4, 5, 6, 7, 8 or 9. Particularly preferred 1, 2-alkanediols having 5 to 12 C atoms used according to the invention are selected from 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-octanediol, 1, 2-decanediol and mixtures thereof. A very particularly preferred combination according to the invention are mixtures of 1, 2-hexanediol and 1, 2-octanediol, preferably in a weight ratio of 10: 1 to 1:10, more preferably from 5: 1 to 1: 5, particularly preferably in the weight ratio of 1: 1 ,

Preferred agents according to the invention contain at least one 1,2-alkanediol having 5 to 12 C atoms, which is described by the formula HO-CH ₂ -CH (OH) - (CH ₂ ) n -CH ₃ , in which n is the numbers 2, 3, 4, 5, 6, 7, 8 or 9, in a total amount of 0.2 to 15 wt .-%, preferably 0.3 to 10 wt .-%, particularly preferably 0.4 to 5 wt .-% and most preferably 0.5 to 2 wt .-%, each based on the weight of the composition, without taking into account any existing propellant. Extremely preferred agents according to the invention contain 0.2-0.5% by weight of 1,2-hexanediol and 0.2-0.5% by weight of 1,2-octanediol, in each case based on the weight of the composition, without to consider existing propellant.

Further preferred agents according to the invention are characterized by a content of the deodorizing agent 3- (2-ethylhexyloxy) -1,2-propanediol, preferably in a total amount of 0.05-5 wt.%, Preferably 0.1-2 wt. %, more preferably 0.2-1.5% by weight, most preferably 0.5-1.0% by weight, based in each case on the weight of the composition, of any propellant which may be present.

Further preferred agents according to the invention are characterized by a content of tropolone (2-hydroxy-2,4,6-cycloheptatrienone), preferably in an amount of 0.001-0.1% by weight, based on the weight of the composition, without to consider existing propellant. Further preferred agents according to the invention are characterized by a content of the deodorant active ingredient triethyl citrate. Triethyl citrate is a known deodorant active which acts as an enzyme inhibitor for esterases and lipases and thus contributes to the broad spectrum effect of agents according to the invention. Preferred agents according to the invention contain from 0.5 to 15% by weight, preferably from 3 to 8% by weight, most preferably from 4 to 6% by weight, in each case based on the weight of the composition, without taking into account any propellant present.

Apocrine sweat is a complex mixture that includes sebum and other fats as well as steroids. Steroids themselves are not water soluble. In order to be carried away with the body fluids, they are usually present as sulfate or as glucuronide. On the skin, the cleavage of these steroid esters in the volatile free steroids by hydrolytic enzymes of the skin bacteria, especially the coryneform bacteria. In principle all bacterial exoesterases are capable of this, but especially the enzymes arylsulfatase and beta-glucuronidase. Compounds which inhibit arylsulfatase or beta-glucuronidase therefore represent preferred deodorant active ingredients according to the invention.

The development of short- and medium-chain fatty acids, which contribute significantly to body odor, begins with the cleavage of skin lipids to branched long-chain fatty acids. The cleavage of the skin lipids, which are present predominantly as glycerol esters, is essentially carried out by Propionibacterium, Corynebacterium A and Staphylococcus species. C ₅ fatty acids and medium-chain C ₆ - - Of the long-chain branched fatty acids, both short-chain C ₂ are represented by the hydrolytic enzymes from a particular Corynebacterium _Ci2 fatty acids are formed, which are mainly responsible for the axillary body odor. In principle, all bacterial exoesterases are capable of this lipid cleavage, but especially the enzyme lipase. Compounds which inhibit lipase are therefore also preferred deodorant agents according to the invention.

Another class of compounds which also results from the bacterial decomposition of the sweat constituents and which contributes to body odor are saturated and unsaturated aldehydes, especially those with a chain length of C ₆ -C 12, in particular hexanal, heptanal, octenal and nonenal. These are formed by beta-cleavage from the hydroperoxides, which are formed under the action of 5-lipoxygenase on unsaturated fatty acids. Compounds which inhibit the enzyme 5-lipoxygenase are therefore also preferred deodorant agents according to the invention.

Furthermore, it is known that highly foul-smelling components of human body odor and halitosis are, in particular, volatile sulfur compounds released by enzymatic reaction (so-called "volatile sulfur compounds" (VSC).) Sulfur-containing compounds come as water-soluble amino acid conjugates with sweat on the human skin They are released by skin bacteria (especially staphylococci and corynebacteria) through enzymatic reaction, an enzyme that is particularly involved in the release of VSCs The role is played by cystathionine beta-lyase. This enzyme breaks down VSCs from the amino acids and is therefore an important cause of the development of body odor. Compounds which inhibit the enzyme cystathionine-beta-lyase, therefore, also according to the invention are preferred deodorant agents.

Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme arylsulfatase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.

Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme beta-glucuronidase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.

Further preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase. Deodorant active ingredients which are preferred according to the invention and which act as lipase inhibitors are selected from the aminomethylene-malonic acid derivatives, the ethylene oxide-propylene oxide copolymers and the salts of phytic acid. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme lipase, in a total amount of 0.001-10 wt.%, Preferably 0.01-5 wt.%, Particularly preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.

Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of 5-lipoxygenase. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme 5-lipoxygenase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, more preferably 0, 1 - 2.5 wt .-%, each based on the weight of the composition, without taking into account any existing propellant.

Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme cystathionine beta-lyase. Further particularly preferred agents according to the invention are characterized by a content of at least one compound which is an inhibitor of the enzyme cystathionine-beta-lyase, in a total amount of 0.001-10% by weight, preferably 0.01-5% by weight, particularly preferably 0, 1 - 2.5 Wt .-%, in each case based on the weight of the composition, without taking into account any existing propellant.

Further particularly preferred agents according to the invention are characterized by a content of at least one cationic phospholipid of the formula KPL,

in which R is an alkyl, alkenyl or hydroxyalkyl group having 8 to 22 C atoms or an acylaminoalkyl group of the formula R ⁵ CONH (C _m H _2m ) -, in which R ⁵ CO is a linear acyl group having 8 to 22 C- Atoms and m = 2 or 3, R ² and R ^{3 are} alkyl groups having 1 to 4 C atoms or hydroxyalkyl groups having 2 to 4 C atoms or carboxyalkyl groups of the formula - (CH ₂ ) _z -COOM, where z is a Is from 1 to 3 and M is hydrogen or an alkali metal cation, x is 1 to 3 and y is (3 - x), M is hydrogen or an alkali metal cation and A ^"is an anion to 22 C atoms are selected from an n-octyl, n-nonyl, n-decyl, n-undecyl, lauryl, n-tridecanyl, myristyl, n-pentadecanyl, cetyl, palmityl , Stearyl, elaidyl, arachidyl, behenyl and a cocyl group. A representative cocyl group consists, based on their total weight, of 4-9% by weight of n-octyl, 4-9% by weight. n-decyl, 45-55% by weight lauryl, 15- 21% by weight of myristyl, 8-13% by weight of palmityl and 7-14% by weight of stearyl groups. Preferred alkenyl groups having 8 to 22 C atoms are selected from a linoleyl group ((9Z, 12Z) octa-deca-9, 12-dien-1-yl) and a linolenyl group ((9Z, 12Z, 15Z) -Octadeca-9,12,15-trien-1-yl). A preferred hydroxyalkyl group having 8 to 22 carbon atoms is selected from a 12-hydroxy-pentachloropyridine group.

Particularly preferred cationic phospholipids of the formula KPL are those in which R is an acylaminoalkyl group of the formula R ⁵ CONH (C _m H _2m ) -, in which R ⁵ CO represents a linear acyl group having 8 to 22 C atoms and m = 3 is.

Preferred linear acyl groups R ⁵ CO having 8 to 22 C atoms are selected from an n-octanoyl, n-nonanoyl, n-decanoyl, n-undecanoyl, lauroyl, n-tridecanoyl, myristoyl, n- Pentadecanoyl, cetoyl, palmitoyl, stearoyl, elaidoyl, arachidoyl, behenoyl and a cocoyl group. A representative cocoyl group consists, based on their total weight, of 4-9% by weight of n-octanoyl, 4-9% by weight of n-decanoyl, 45-55% by weight of lauroyl, 15-21 % By weight of myristoyl, 8-13% by weight of palmitoyl and 7-14% by weight of stearoyl groups. Particularly preferred linear acyl groups R ⁵ CO are selected from a cocoyl group, a lauroyl group (n-CiiH ₂₃ CO), a myristoyl group (n-Ci ₃ H ₂₇ CO) and a linoleoyl group ((9Z, 12Z ) -Octadeca-9,12-dien-1-oyl). extraordinarily preferred linear acyl groups R CO are selected from a cocoyl group, a lauroyl group (n-CiiH ₂₃ CO) and a myristoyl group (n-Ci ₃ H ₂₇ CO).

Preferred alkyl groups having 1 to 4 C atoms are a methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 2-methylpropyl and a tert-butyl group. Particularly preferred is the methyl group.

Preferred hydroxyalkyl groups having 2 to 4 C atoms are a 2-hydroxyethyl and a 1-hydroxyethyl group.

Preferred carboxyalkyl groups of the formula - (CH ₂ ) _z -COOM with z = 1 to 3 are a carboxymethyl, a carboxyethyl and a carboxy-n-propyl group.

Preferred alkali metal cations are selected from sodium and potassium cations; Na ⁺ is particularly preferred. Preferred anions are selected from sulfate, chloride, phosphate, nitrate, bicarbonate and acetate, with a chloride anion being particularly preferred.

Preferred agents according to the invention contain as deodorant active ingredient a cationic phospholipid of the formula KPL,

wherein R is an acylaminoalkyl group of the formula R ⁵ CONH (C _m H _2m ) - wherein R ⁵ CO is selected from a cocoyl group, a lauroyl group, a myristoyl group and a linoleoyl group, and m = 3, R ² and R ³ Are methyl, x = 2, y = 1, M is a sodium ion and A ^"is a chloride ion Preferably at least one cationic phospholipid of the formula KPL having the abovementioned features in a total amount of 0.05-2% by weight is preferred 0.1 - 1 wt .-%, particularly preferably 0.15 - 0.4 wt .-%, contained, in each case based on the weight of the composition, without taking into account any propellant contained.

Particularly preferred agents according to the invention contain a cationic phospholipid of the formula KPL,

in which R is a cocoylaminopropyl group (also referred to as cocamidopropyl group), R ² and R ^{3 are} methyl groups, x = 2, y = 1, M is a sodium ion and A ^"is a chloride ion and which is under the INCI Description Cocamidopropyl PG-Dimonium Chloride Phosphate is available, in a total amount of 0.05 to 2 wt .-%, preferably 0 1 to 1 wt .-%, particularly preferably 0, 15 to 0.4 wt .-%, respectively based on the weight of the agent, without taking into account any propellant contained.

Further particularly preferred agents according to the invention contain a cationic phospholipid of the formula KPL,

in which R is a myristoylaminopropyl group, R ² and R ^{3 are} methyl groups, x = 2, y = 1, M is a sodium ion and A ^"is a chloride ion and is available under the INCI name myristamidopropyl PG-Dimonium Chloride Phosphate, in one Total amount of 0.05 to 2 wt .-%, preferably 0.1 to 1 wt .-%, particularly preferably 0.15 to 0.4 wt .-%, each based on the weight of the composition, without optionally contained propellant to take into account.

in which R is a lauroylaminopropyl group, R ² and R ^{3 are} methyl groups, x = 2, y = 1, M is a sodium ion and A ^"is a chloride ion, in a total amount of 0.05-2% by weight, preferably 0, 1 to 1 wt .-%, particularly preferably 0.15 to 0.4 wt .-%, each based on the weight of the composition, without taking into account any propellant contained.

Further inventively preferred deodorant active ingredients are odor absorbers, deodorizing ion exchangers, antimicrobial agents, prebiotic components and enzyme inhibitors or, more preferably, combinations of said active ingredients.

Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention. Among the silicates particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum. Further preferred odor absorbers are, for example, zeolites, zinc ricinoleate, cyclodextrins, certain metal oxides, such as As alumina, and chlorophyll. They are preferably in a total amount of 0.1 to 10 wt .-%, more preferably 0.5 to 7 wt .-% and most preferably 1-5 wt .-%, each based on the total composition without propellant, included.

Preferred deodorant or antiperspirant compositions according to the invention contain at least one deodorant active ingredient which is selected from silver salts, aromatic alcohols of the structure AA-1 having the abovementioned substituents, 1,2-alkanediols having 5 to 12 carbon atoms, alpha- (2- Ethylhexyl) glycerol ether (3- (2-ethylhexlyoxy) -1, 2-propanediol), tropolone, triethyl citrate, cationic phospholipids of the formula KPL having the abovementioned substituents, and mixtures thereof.

Further preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient in a total amount of 0.1 to 20 wt .-%, preferably 0.3 to 15 wt .-%, particularly preferably 0.5 - 5 wt .-%, wherein the wt .-% - based on the total weight of the composition, without taking into account any existing propellant.

In a further particularly preferred embodiment, the compositions according to the invention contain both at least one deodorant active ingredient in a total amount of 0.1-40% by weight, preferably 0.3-20% by weight, particularly preferably 0.5-15% by weight. -%, most preferably 1, 5 - 5 wt .-%, and at least one antiperspirant aluminum salt in a total amount of 2-40 wt .-%, preferably 10-35 wt .-%, particularly preferably 1 1 - 28 wt. % and most preferably 12-20% by weight, the weight percentages being based on the total weight of the water-free and ligand-free active substance (USP) in the composition, without taking account of any propellant present.

Compositions of the invention may be in solid, semi-solid, liquid, disperse, emulsified, suspended or gel form. Furthermore, the compositions according to the invention for use as aerosol can be packaged, that is, they are packaged in a pressure vessel, from which they can be sprayed by means of a propellant. Furthermore, the agents according to the invention can be sprayed as a propellant-free pump spray.

In a particularly preferred embodiment, the compositions according to the invention are in liquid or in viscous, flowable form. The application can preferably be carried out with spray devices. These spraying devices contain in a container a filling of the liquid, viscous-flowable, suspension-like or pulverulent deodorant or antiperspirant agent according to the invention. The filling can be under the pressure of a propellant (compressed gas cans, aerosols, aerosols), or it can be a mechanically operated pump sprayer without propellant (pump sprays). The containers have a removal device, preferably in the form of valves, which is the removal of the contents as a mist, Allow smoke, foam, powder, paste or jet of liquid. As a container for the sprayers are mainly cylindrical vessels made of metal (aluminum, tinplate, volume preferably up to 1000 ml), protected or non-splitting glass or plastic (volume preferably a maximum of 220 ml) or splitterndem glass or plastic (volume preferably a maximum of 150 ml ) in question. Creamy, gelatinous, pastose and liquid agents can be packaged, for example, in pump, spray or squeeze dispensers, in particular in multi-chamber pumping, multi-chamber spray or multi-chamber squeeze dispensers. The packaging for the compositions according to the invention may be opaque, but also transparent or translucent.

For the purposes of the invention, the term liquid also includes any solid dispersions in liquids. Compositions according to the invention may also be present as pastes, ointments, lotions or creams. Solid funds can be present as a loose powder, pressed powder or as a pen.

In the case of liquid or low to medium viscosity agents, the application can preferably also be carried out with a roller applicator, as described e.g. is known from the field of deodorant scooters. Such scooters have a ball mounted in a ball bed which can be moved by movement over a surface. The ball absorbs some of the agent to be distributed and conveys this to the surface to be treated.

The application can also be carried out with substrates which are acted upon by a preparation according to the invention. Especially preferred are wet wipes, i. prefabricated for the user, preferably individually packaged, wet wipes, such as. B. from the field of glass cleaning or from the field of wet toilet paper are well known. Such wet wipes, which may advantageously also contain preservatives, are then preferably impregnated or applied with an agent according to the invention, preferably they are individually packaged. You can z. B. be used as a deodorant cloth, which is particularly interesting for use on the go.

Preferred substrate materials are preferably selected from porous sheet-like cloths. They can be made of a fibrous or cellular flexible material which has sufficient mechanical stability and softness for application to the skin. These wipes include cloths of woven and non-woven synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam.

Preferably, conventional cloths made of non-woven material (nonwovens) are used here. Nonwovens are generally defined as adhesively bonded fibrous products having a mat or layered fibrous structure, or those comprising fibrous mats in which the fibers are randomly or randomly distributed. The fibers may be natural such as wool, silk, jute, hemp, cotton, flax, sisal or ramie; or synthetically, such as rayon, cellulose esters, polyvinyl derivatives, polyolefins, polyamides or polyesters. In general, each fiber diameter or titer is for the present invention suitable. The nonwoven fabrics employed herein tend not to rupture or disintegrate due to the random or random arrangement of fibers in the nonwoven material which impart excellent strength in all directions. Preferred porous and flat cleaning cloths consist of one or different fiber materials, in particular of cotton, refined cotton, polyamide, polyester or mixtures of these. The substrates in fabric form preferably have an area of from 10 to 400 cm ² , preferably from 50 to 300 cm ² , more preferably from 100 to 200 cm ² . The grammage of the cloth material is usually 20 to 1000 g / m ² , preferably 30 to 500 g / m ² and in particular 50 to 150 g / m ² . Deodorizing or antiperspirant substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting a composition according to the invention onto a substrate.

The agents according to the invention, preferably liquid agents, may also be multiphase, the phases may e.g. horizontally, so one above the other, or vertically, so next to each other, be arranged. It may also be a disperse system in which e.g. the solid constituents are distributed inhomogeneously in the liquid matrix, so that such a dispersed system should be shaken before use.

It should be noted at this point that the statement wt .-%, unless stated otherwise, in each case refers to the total weight of the agent according to the invention, without taking into account any existing propellant.

The compositions of the invention contain a cosmetically acceptable carrier, which preferably comprises at least one component selected from water, ethanol, a liquid under normal conditions cosmetic oil, which is not a fragrance and no essential oil, and talc and mixtures thereof. Under normal conditions liquid cosmetic oils are immiscible with water. For the purposes of the present application, "normal conditions" are a temperature of 20 ° C. and a pressure of 1013.25 mbar. Melting point data likewise relate to a pressure of 1013.25 mbar.

In a first preferred embodiment, the agent according to the invention contains water in an amount of 8-98% by weight, preferably 20-80% by weight, more preferably 30-60% by weight, even more preferably 40-50% by weight. , in each case based on the total weight of the agent according to the invention, without taking into account any propellant present.

Further preferred agents according to the invention, in particular antiperspirant suspension sprays or ethanol-based deodorant sprays, are essentially anhydrous, ie they contain 0 to at most 7% by weight, preferably 0.5 to 5% by weight, more preferably 1 to 4% by weight .-%, most preferably 1, 5 to 3 wt .-% free, that is, not molecularly bound, water, wherein also contents of free water of 1, 6 - 2.4 wt .-%, 1, 7 - 2.3 wt .-% and 1, 8 - 2.2 wt .-% may be preferred and wherein the amounts refer to the weight of the composition, without taking into account any existing propellant. The content of water of crystallization, water of hydration or similar molecularly bound water contained in the constituents used, in particular in the antiperspirant active substances, does not constitute free water in the context of the present application. Antiperspirant suspension sprays and antiperspirant are therefore particularly preferred. Suspension sticks containing at least one antiperspirant aluminum salt in a total amount of 2-40% by weight, preferably 10-35% by weight, more preferably 1-1-28% by weight and most preferably 12-20% by weight, wherein the weight percentages are based on the total weight of the water-free and ligand-free active substance (USP) in the total composition; furthermore 0 to a maximum of 7% by weight, preferably 0.5 to 5% by weight, more preferably 1 to 4% by weight, most preferably 1, 5 to 3% by weight free, that is to say not molecularly bound , Water, and at least one liquid cosmetic liquid under normal conditions, wherein the quantities are based on the weight of the composition, without taking into account any existing propellant.

If the agent according to the invention is present in particulate form, for example as a deodorizing powder, then the particles can be aftertreated, for example by rounding the particles of the agent. The rounding can be done in a standard roundabout. An inventive agent in particulate form can be particularly with nonionic surfactants, perfume oil and / or foam inhibitors or formulations containing these ingredients, preferably with amounts up to 20 wt .-% of active ingredient, in particular with amounts of 2 to 18 wt .-% of active substance , in each case based on the aftertreated product, in a conventional manner, preferably in a mixer or optionally a fluidized bed, aftertreat.

Further preferred embodiments of the invention are characterized in that the cosmetically or dermatologically acceptable carrier is present as powder, in stick form, as aerosol spray, pump spray, liquid or gel roll-on application, cream, lotion, solution, gel or on a substrate. Preferred agents according to the invention, which are in the form of an emulsion, suspension or stick, preferably further comprise at least one liquid under normal conditions cosmetic oil, which is not a fragrance and no essential oil.

The cosmetic oil is liquid under normal conditions. Essential oils according to the invention are understood to mean mixtures of volatile components which are prepared by steam distillation from vegetable raw materials, such as. B. citrus oils.

The total amount of liquid under normal conditions cosmetic oils that are not fragrance and no essential oil is in accordance with the invention preferred and preferably used Compositions 1-95% by weight, preferably 5-90% by weight, more preferably 30-75% by weight, most preferably 50-60% by weight, the amounts given being by weight of the composition without to consider any existing propellant.

Further agents preferred according to the invention comprise at least one cosmetic oil which is not a fragrance and no essential oil, in a total amount of 1-70% by weight, preferably 5-50% by weight, particularly preferably 9-25% by weight, extremely preferably 15-20% by weight, based in each case on their total weight, without taking into account any propellant present.

In the case of cosmetic oils, a distinction is made between volatile and non-volatile oils. Non-volatile oils are understood as meaning oils having a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C and an ambient pressure of 1013 hPa. Volatile oils are understood to mean those oils which, at 20 ° C. and an ambient pressure of 1013 hPa, have a vapor pressure of 2.66 Pa - 40,000 Pa (0.02 mm - 300 mm Hg), preferably 10 - 12000 Pa (0.1-0.200 Pa). 90 mm Hg), more preferably 13-3000 Pa, most preferably 15-500 Pa.

Volatile cosmetic oils are usually selected from cyclic silicone oils having the INCI name Cyclomethicone. The INCI name cyclomethicones is understood to mean, in particular, cyclotrisiloxane (hexamethylcyclotrisiloxane), cyclotetrasiloxane (octamethylcyclotetrasiloxane), cyclopentasiloxane (decamethylcyclopentasiloxane) and cyclohexasiloxane (dodecamethylcyclohexasiloxane). These oils have a vapor pressure of about 13-15 Pa at 20 ° C. Cyclomethicones are known in the art as well-suited oils for cosmetic compositions, especially for deodorizing compositions such as sprays and sticks. Due to their persistence in the environment, it may be preferred according to the invention to dispense with the use of cyclomethicones. In a particularly preferred embodiment, the compositions according to the invention and used according to the invention contain 0 to less than 1 wt .-%, preferably at most 0, 1 wt .-%, cyclomethicones, based on the weight of the composition, wherein any existing blowing agent is not taken into account.

An inventively preferred cyclomethicone substitute is a mixture of Ci ₃ -Ci ₆ - isoparaffins, C ₁₂ - C ₁₄ -si paraffins and C ₁₃ - C ₁₅ alkanes whose viscosity at 25 ° C in the range of 2 to 6 mPas and the a vapor pressure at 20 ° C in the range of 10 to 150 Pa, preferably 100 to 150 Pa has. Such a mixture is z. B. under the name SiClone SR-5 from Presperse Inc. available.

Further preferred volatile silicone oils are selected from volatile linear silicone oils, in particular volatile linear silicone oils having 2-10 siloxane units, such as hexamethyldisiloxane (L ₂ ), octamethyltrisiloxane (L ₃ ), decamethyltetrasiloxane (L ₄ ), as described e.g. In the commercial products DC 2-1 184, Dow ^Corning® 200 (0.65 cSt) and Dow ^Corning® 200 (1.5 cSt) from Dow Corning, and low molecular weight phenyl trimethicone having a vapor pressure at 20 ° C of about 2000 Pa as available, for example, from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.

Preferred antiperspirant compositions of the present invention contain at least one volatile silicone oil, which may be cyclic or linear, because of the drier skin feel and faster drug release.

Other preferred agents of the present invention contain at least one volatile non-silicone oil because of the drier skin feel and faster drug release. Preferred volatile non-silicone oils are selected from C ₈ -C ₆ -isoparaffins, in particular from isononane, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and isohexadecane, and mixtures thereof. Preference is given to Ci ₀ -Ci ₃ isoparaffin mixtures, in particular those having a vapor pressure at 20 ° C of 10 - 400 Pa, preferably 13 - 100 Pa.

This at least one C ₈ -C ₆ -lsoparaffin preferably in a total amount of 1 - 50 wt .-%, preferably 3 - 35 wt .-%, particularly preferably 5 - 30 wt .-%, exceptionally preferably 8 - wt 20th -%, in each case based on the total weight of the composition, without taking into account any existing propellant.

Further agents preferred according to the invention contain at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils. Residues of components insoluble in the composition, such as antiperspirant actives (= antiperspirant aluminum salts) or talc, can be successfully masked with a nonvolatile oil. In addition, with a mixture of different oils, especially non-volatile and volatile oils, parameters such as skin feel, residue visibility and stability of the composition of the invention can be finely regulated and better adapted to consumer needs.

Agents preferred according to the invention are characterized in that the cosmetic oil, which is not a perfume and an essential oil, at least a volatile oil with a vapor pressure of 10 - 3000 Pa at 20 ° C, which is no perfume and no essential oil, in a total amount from 10 to 100 wt .-%, particularly preferably 30 to 80 wt .-%, each based on the total weight of the cosmetic oils comprises.

Of course, it is also possible to formulate compositions according to the invention with a low proportion of volatile oils - that is to say with 0.5 - 15% by weight of volatile oils, based on the total weight of the composition - or even without volatile oils.

Oils which are particularly preferred according to the invention are esters of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated. It should be noted that some esters of linear or branched C ₁ -C 22 -alkanols or C ₄ -C ₂ 2 -alkenols and some triesters of glycerol with linear or branched C ₂ -C ₂ 2 carboxylic acids, which may be saturated or unsaturated, are solid under normal conditions, such as cetyl stearate or glycerol tristearate (= stearin). According to the invention, these esters, which are solid under normal conditions, do not constitute cosmetic oils since they do not fulfill the condition "liquid under normal conditions." The assignment as to whether such an ester is liquid or solid under normal conditions is within the general knowledge of the person skilled in the art.

Preference is given to esters of linear or branched saturated fatty alcohols having 2-5 carbon atoms with linear or branched saturated or unsaturated fatty acids having 3-18 carbon atoms which may be hydroxylated. , Preferred examples thereof are isopropyl palmitate, isopropyl stearate, isopropyl myristate, 2-hexyldecyl stearate, 2-hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate and 2-ethylhexyl stearate. Also preferred are isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotri- decyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyl dodecyl palmitate, butyloctanoic acid 2-butyloctanoate, diisotridecyl acetate, n-butyl stearate , n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, Ethylenglycoldioleat, Ethylenglycoldipalmitat, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, C ₁₂ -C ₅ alkyl lactate and di-C ₂ - Ci ₃ -Alkylmalat and the benzoic acid esters of linear or branched C ₈ - ₂₂ nolen -Alka-. Particularly preferred are benzoic acid-Ci ₂ -Ci ₅ -alkyl esters, for. B. available as a commercial product Further preferred oil components according to the invention are selected from the C ₈ -C ₂₂ fatty alcohol esters of monohydric or polyhydric C ₂ -C ₇ hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid , Such esters based on linear C _14/15 alkanols, eg. B. C ₁₂ .C ₁₅ -Alkyllactat, and from branched in the 2-position C _12/13 alkanols are under the trade name Cosmacol ^® by the company Nordmann, Rassmann GmbH & Co, Hamburg, relate, in particular the commercial products Cosmacol ^® ESI , Cosmacol ^® EMI and Cosmacol ^® ETI, Finsolv ^® TN (C ₂ -C ₅ -alkyl), and isostearyl benzoate, z. As available as Finsolv ^® SB, 2-ethylhexyl, z. B. available as Finsolv ^® EB, and benzoic acid 2-octyldodecylester, z. As available as Finsolv ^® BOD.

As a particularly advantageous, for. As for the drug release, the use of isopropyl esters of Ci ₂ -Ci ₈ carboxylic acids, in particular the use of isopropyl myristate, and more preferably mixtures of isopropyl myristate with Ci ₀ -Ci ₃ isoparaffin mixtures, the latter preferably with a vapor pressure at 20 ° C of 10 - 400 Pa, proved.

Compositions preferred according to the invention comprise at least one ester of linear or branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids containing 2 to 30 carbon atoms, which may be hydroxylated, in a total amount of 1 to 30% by weight. , preferably 5 - 26 wt .-%, particularly preferably 9 - 24 wt .-%, most preferably 12 - 17 wt .-%, each based on the weight of the total Composition, without taking into account any existing propellant. Another particularly preferred ester oil is triethyl citrate.

Preferred cosmetic agents are characterized in that these cosmetic agents contain an ester d) of a C ₃ -C ₃₀ carboxylic acid, preferably an ester d) from the group consisting of 2-ethylhexyl palmitate, isopropyl palmitate and triethyl citrate.

Further inventively preferred products contain triethyl citrate and at least one C ₈ -C | ₆ - Isoparaffin selected from isononane, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and isohexadecane and mixtures of these isoparaffins. Further inventively preferred products contain triethyl citrate and at least one C ₈ -C ₆ -isoparaffin, selected from isononane, isodecane, isoundecane, isododecane, isotridecane and mixtures of these C ₈ -C | ₆ - isoparaffins. Further inventively preferred products include triethyl citrate and a mixture of isodecane, isoundecane, isododecane and isotridecane.

Further non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction. Preferred alcohol oils are 2-hexyldecanol, 2-octyldodecanol and 2-ethylhexyl alcohol. Also preferred is isostearyl alcohol. Other preferred nonvolatile oils are selected from mixtures of Guerbet alcohols and Guerbet alcohol esters, e.g. For example, 2-hexyldecanol and 2-hexyldecyl laurate.

The term "triglyceride" used hereinafter means "glycerol triester". Further preferred nonvolatile oils according to the invention are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C ₈ . ₃₀ fatty acids, provided that they are liquid under normal conditions. Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like. Particularly preferred are synthetic triglyceride oils, in particular Capric / Caprylic triglycerides, z. As the commercial products Myritol ^® 318 or Myritol ^® 331 (BASF / Cognis) with unbranched fatty acid residues and glyceryl triisostearin and glyceryl tri (2-ethylhexanoate) with branched fatty acid residues. Such triglyceride oils preferably account for less than 50% by weight of the total weight of all cosmetic oils in the composition of the invention. Particularly preferably, the total weight of triglyceride oils 0.5 to 10 wt .-%, preferably 1-5 wt .-%, each based on the total composition, without taking into account any existing propellant.

Further according to the invention particularly preferred non-volatile non-silicone oils are selected from the dicarboxylic acid esters of linear or branched C ₂ -C ₀ -alkanols, in particular diisopropyl propyl adipate, di-n-butyl adipate, di (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate, and di- (2-hexyldecyl) succinate.

Further inventively particularly preferred non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C ₈ -22-alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. PPG-2 myristyl ether and PPG-3 myristyl ether.

Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C ₃ . ₂ 2-alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for. PPG-14 butyl ether, PPG-9 butyl ether, PPG-10-butanediol and PPG-15 stearyl ether.

Further according to the invention particularly preferred non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with C ₆ -C ₂ o-alcohols, z. As di-n-caprylylcarbonat (Cetiol ^® CC) or di- (2-ethylhexyl) carbonate (Tegosoft DEC). Esters of carbonic acid with C 1 -C 8 -alcohols, eg. As glycerol carbonate or propylene carbonate, however, are not suitable as a cosmetic oil compounds.

Further oils which may be preferred according to the invention are selected from the esters of dimers of unsaturated C ₂ -C ₂ 2 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C ₂ -C ₈ -alkanols or with polyvalent linear or branched C ₂ -C ₆ -alkanols. The total weight of dimer fatty acid esters is particularly preferably 0.5-10% by weight, preferably 1-5% by weight, in each case based on the total composition, without taking into account any blowing agent which may be present.

Other cosmetic oils which are particularly preferred according to the invention are selected from nonvolatile silicone oils. Preferred nonvolatile silicone oils according to the invention are selected from linear polyalkylsiloxanes having a kinematic viscosity at 25 ° C. of at least 5 cSt to 2000 cSt, in particular selected from linear polydimethylsiloxanes having a kinematic viscosity at 25 ° C. of from 5 cSt to 2000 cSt, preferably from 10 to 350 cSt , particularly preferably 50 - 100 cSt, as z. B. under the trade names Dow Corning ^® 200 and Xiameter PMX Dow Corning or Xiameter are available. Further preferred nonvolatile silicone oils are phenyltrimethicones having a kinematic viscosity at 25 ° C. of from 10 to 100 cSt, preferably from 15 to 30 cSt, and also cetyldimethicones.

Natural and synthetic hydrocarbons preferred according to the invention are selected from paraffin oils, isohexadecane, isoeicosane, polyisobutenes and polydecenes, which, for example, are disclosed in US Pat. B. under the name Emery ^® 3004, 3006, 3010 or under the name ^® from Albemarle Ethylflo or Nexbase ^® 2004G available from Nestle, and 1, 3-di- (2-ethylhexyl) -cyclohexane. Compositions according to the invention and used according to the invention may also be present as decorative body powders. The main ingredient of such carriers is talc. Body powders according to the invention and used according to the invention can be present as loose powder or as compact powder. The powder base for loose powders usually comprises at least 70 wt .-% talc, 2 - 10 wt .-% metal soaps, in particular the stearates of magnesium, zinc, titanium, calcium and aluminum, preferably magnesium stearate, besides other powdered ingredients selected from silica , Starch, titanium dioxide, zinc dioxide, kaolin, calcium carbonate and magnesium carbonate. Compact powders usually contain talc in amounts of less than 70% by weight, for example 5 to 60% by weight, and also oils and / or waxes in a total amount of 2 to 15% by weight, based on the total composition according to the invention.

The compositions according to the invention and used according to the invention optionally contain further excipients, auxiliaries and active substances.

Deodorant or antiperspirant sticks according to the invention may be in gelled form, on an anhydrous basis, based on a W / O emulsion, based on an O / W emulsion, based on a water-oil multiple emulsion, based on a nanoemulsion and are based on a microemulsion, wherein the oil phase contain at least one silicone component or may consist of at least one silicone component. Furthermore, the compositions according to the invention, which are formulated as deodorant or antiperspirant sticks, can be prepared on anhydrous fat basis, based on a polyol-in-oil emulsion based on an oil-in-polyol emulsion based on a polyol oil. Multiple emulsion, based on a nanoemulsion and based on a microemulsion, wherein the polyol phase may be anhydrous or may have only a low water content. Gel sticks can be formulated on the basis of fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, polyamides, polyamide derivatives, polysaccharides such as xanthan, polyglucomannans, guar, konjac, celluloses or starches, polyacrylates, polyacrylate derivatives and other gelling agents.

Aerosol sprays, pump sprays, roll-on applications and creams can be in the form of a water-in-oil emulsion, oil-in-water emulsion, silicone oil-in-water emulsion, water-in-oil microemulsion, oil-in-water Microemulsion, silicone oil-in-water microemulsion, polyol-in-oil emulsion, oil-in-polyol emulsion, polyol-oil multiple emulsion, anhydrous suspension, preferably anhydrous oil-based suspension, alcoholic solution, especially ethanolic solution, hydroalcoholic solution, in particular solutions containing more than 50% by weight of a water-ethanol mixture, glycolic solution, in particular as a solution in propylene glycol, glycerol, dipropylene glycol and (under normal conditions) liquid polyethylene glycols, hydroglycolic solution, polyol solution, water-polyol Solution, aqueous gel, lipogel and as an oil. All said compositions may be thickened, for example based on fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12- Hydroxystearic acid, carbomer and carbopol type polyacrylates, polyacrylamides and polysaccharides, which may be chemically and / or physically modified. The agents may be transparent, translucent or opaque.

Lipid or wax matrix

If the compositions according to the invention are in the form of a stick, they preferably contain a lipid or wax matrix comprising at least one lipid or wax component with a melting point> 50 ° C.

Preference according to the invention, for example, natural vegetable waxes, z. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti. For the purposes of the invention, it may be particularly preferred to use hydrogenated or hardened waxes. As a wax component and chemically modified waxes, especially the hard waxes, such as. As montan ester waxes, hydrogenated jojoba waxes and Sasol waxes used. Synthetic waxes, which are also preferable in the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C ₂ ° C ₄₀ dialkyl esters of dimer acids, C ₃₀ -5o-alkyl and alkylaryl esters of Alkylbienenwachs and dimer fatty acids.

A particularly preferred wax component is selected from at least one ester of a saturated monohydric C ₆ -C ₆ o-alcohol and a saturated C ₈ -C ₃₆ monocarboxylic acid. According to the invention, lactides, the cyclic double esters of α-hydroxycarboxylic acids of the corresponding chain length, also belong thereto. Esters of fatty acids and long-chain alcohols have proven to be particularly advantageous for the composition according to the invention because they give the antiperspirant preparation excellent sensory properties and the pen a high overall stability. The esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols. Also esters of aromatic carboxylic acids or hydroxycarboxylic acids (eg 12-hydroxystearic acid) and saturated branched or unbranched alcohols can be used according to the invention, provided that the wax component has a melting point> 50 ° C. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkane carboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms, which has a melting point > 50 ° C.

In particular, the wax component Ci ₆ -36-alkyl stearates and Ci ₈ -38-Alkylhydroxystearoylstea-, C ₂ o-4o-Alkylerucate and Cetearylbehenat be advantageous. The wax or the wax components have a melting point> 50 ° C, preferably> 60 ° C, on. A particularly preferred embodiment of the invention contains as wax component a C ₂₀ -C ₄₀ alkyl stearate. A further particularly preferred embodiment of the invention contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate.

Other preferred lipid or wax components with a melting point of> 50 ° C are the triglycerides of saturated and optionally hydroxylated C _{_2-30} fatty acids such as hydrogenated triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin), or glyceryl tri-12 hydroxystearate, further synthetic Vollester of fatty acids and glycols or poly-ols having 2 - 6 carbon atoms as long as they have a melting point above 50 ° C, for example, preferably C ₁₈ - C ₃₆ acid triglyceride (Syncrowax ^® HGL-C). According to the hydrogenated castor oil as a wax component, available for example as a commercial product Cutina ^® HR, is particularly preferred.

Further preferred lipid or wax components with a melting point> 50 ° C are the saturated linear d ₄ - C ₃₆ carboxylic acids, in particular myristic acid, palmitic acid, stearic acid and behenic acid and mixtures of these compounds.

Preferred deodorant or antiperspirant sticks according to the invention contain a lipid or wax component selected from esters of a saturated, monohydric C ₆ -C ₆ o-alkanol and a saturated C ₈ -C ₃₆ monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C ₂₀ - C ₄₀ alkyl stearate, glycerol triesters of saturated linear C ₁₂ - C ₃₀ carboxylic acids which may be hydroxylated, candelilla wax, carnauba wax, beeswax, saturated linear d ₄ - C ₃₆ carboxylic acids and mixtures of the aforementioned substances. Particularly preferred lipid or wax component mixtures are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. Further particularly preferred lipid or wax component mixtures are selected from mixtures of C ₂₀ -C ₄₀ -alkyl stearate, hardened castor oil, palmitic acid and stearic acid.

Further preferred deodorant or antiperspirant sticks according to the invention comprise lipid or wax component (s) in total in amounts of 4 to 20% by weight, preferably 8 to 15% by weight, based on the total composition. In a particularly preferred embodiment, the ester (s) is / are a saturated, monohydric C ₆ -C ₆ o-alcohol and a saturated C ₈ -C ₃₆ monocarboxylic acid which represents the lipid or wax component (s) , in amounts of 2 to 10% by weight, preferably 2 to 6% by weight, based on the total composition.

Oil-in-water emulsifiers

The cosmetic compositions according to the invention which are formulated as emulsion, in particular as oil-in-water emulsion or polyol-in-water emulsion, preferably contain at least one nonionic oil-in-water emulsifier having an HLB value of more than 7 to 20. These are emulsifiers generally known to the person skilled in the art, as described, for example, in Kirk-Othmer, "Encyclopedia". pedia of Chemical Technology, 3rd Ed., 1979, Vol 8, pages 913-916. For ethoxylated products, the HLB value is calculated according to the formula HLB = (100-L): 5, where L is the weight fraction the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent.

In selecting nonionic oil-in-water emulsifiers which are suitable according to the invention, it is particularly preferable to use a mixture of nonionic oil-in-water emulsifiers in order to optimally adjust the stability of the stick compositions according to the invention. The individual emulsifier components deliver a proportion to the total HLB value or mean HLB value of the oil-in-water emulsifier mixture in accordance with their proportion of the total amount of oil-in-water emulsifiers. According to the invention, the average HLB value of the oil-in-water emulsifier mixture is 10-19, preferably 12-18 and particularly preferably 14-17. In order to achieve such average HLB values, preference is given to oil-in-water emulsifiers from the HLB value ranges 10 - 14, 14 - 16 and possibly 16 - 19 combined. Of course, the oil-in-water emulsifier mixtures may also contain nonionic emulsifiers with HLB values in the range of> 7-10 and 19-20; Such emulsifier mixtures may also be preferred according to the invention. However, in another preferred embodiment, the deodorant or antiperspirant compositions of the present invention may also contain only a single oil-in-water emulsifier having an HLB in the range of 10-19.

Preferred deodorant or antiperspirant compositions according to the invention comprise at least one nonionic oil-in-water emulsifier selected from ethoxylated C ₈ -C ₂₄ -alkanols with an average of 10 to 100 mol of ethylene oxide per mole of ethoxylated C ₈ -C ₂ -alkyl. Carboxylic acids with an average of 10 to 100 moles of ethylene oxide per mole, silicone copolyols having ethylene oxide units or with ethylene oxide and propylene oxide units, alkyl mono- and oligoglycosides having 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs, ethoxylated sterols, partial esters of polyglycerols esterified with 2 to 10 glycerol units and with 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C _{8 to} C ₃₀ fatty acid residues, if they have an HLB value of more than 7, and mixtures of the abovementioned substances.

The ethoxylated C ₈ -C ₂ alkanols have the formula R 0 (CH ₂ CH ₂ 0) _n H, where R is a linear or branched alkyl and / or alkenyl radical having 8-24 carbon atoms and n, the average number of ethylene oxide units per molecule, for numbers from 10 to 100, preferably 10 to 30, moles of ethylene oxide to 1 mole of caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol , Petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. Adducts of 10 to 100 moles of ethylene oxide onto technical fatty alcohols containing 12 to 18 carbon atoms, such as, for example, coconut, palm, palm kernel or tallow fatty alcohol, are also suitable. Preferred cosmetic compositions contain a nonionic surfactant e) from the group of polyalkylene glycol ether, preferably selected from the group of alkoxylated C ₈ -C ₂ 4-alkanols with on average 10-100 mol of alkylene oxide per mole, preferably from the group of ethoxylated C ₂ -C- | ₈ - Alkanols with an average of 10 to 30 moles of ethylene oxide per mole.

The ethoxylated C ₈ -C have ₂ 4-carboxylic acids of the formula R (OCH ₂ CH 2) NOI l, wherein R is a linear or branched saturated or unsaturated acyl group having 8 -24 carbon atoms, and n, the average number of ethylene oxide units per molecule, for numbers from 10 to 100, preferably 10 to 30, mol of ethylene oxide to 1 mol of caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, cetylic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid , Arachic acid, gadoleic acid, behenic acid, erucic acid and brassidic acid and their technical mixtures. Adducts of 10 to 100 moles of ethylene oxide with technical fatty acids containing 12 to 18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty acid, are also suitable. Particularly preferred are PEG-50 monostearate, PEG-100 monostearate, PEG-50 monooleate, PEG-100 monooleate, PEG-50 monolaurate and PEG-100 monolaurate.

Particular preference is given to C ₂ -C ₈ -alkanols or C ₂ -C ₈ carboxylic acids each having 10 to 30 units of ethylene oxide per molecule and mixtures of these substances, in particular ceteth-12, ceteth-20, ceteth-30, steareth 12, Steareth-20, Steareth-30, Laureth-12 and Beheneth-20. Furthermore, preference is given to using C ₈ -C ₂₂ -alkyl mono- and -oligoglycosides. C ₈ -C ₂₂ -alkyl mono- and -oligoglycosides are known, commercially available surfactants and emulsifiers. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8-22 carbon atoms. With regard to the glycoside radical, monoglycosides in which a cyclic sugar residue is glycosidically linked to the fatty alcohol and oligomeric glycosides having a degree of oligomerization of up to about 8, preferably 1-2, are suitable. The degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products. Products which are obtainable under the name Plantacare ^®, a glucosidically bonded C ₈ -C ₁₆ alkyl group containing at an oligoglucoside whose average degree of oligomerization at 1-2, in particular 1, 1 - 1, 4 is located. Particularly preferred C ₈ -C ₂₂ alkyl mono- and oligoglycosides are selected from octyl glucoside, decyl glucoside, lauryl glucoside, palmityl glucoside, isostearyl glucoside, stearyl glucoside, arachidyl glucoside and behenyl glucoside and mixtures thereof. The glucamine-derived acylglucamides are also suitable as nonionic oil-in-water emulsifiers.

Also ethoxylated sterols, in particular ethoxylated soy sterols, according to the invention are suitable oil-in-water emulsifiers. The degree of ethoxylation must be greater than 5, preferably at least 10 to have an HLB value greater than 7-20. Suitable commercial products are, for. PEG-10 Soy Sterol, PEG-16 Soy Sterol and PEG-25 Soy Sterol.

Furthermore, partial esters of polyglycerols having 2 to 10 glycerol units and having 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C ₈ -C ₃₀ fatty acid residues are preferably esterified, provided that they have an HLB value in the range of more than 7 to 20 have. Particularly preferred Diglycerinmonocaprylat, Diglycerinmonocaprat, diglycerol are monolaurate, Triglycerinmonocaprylat, Triglycerinmonocaprat, triglycerol, Tetraglycerin- monocaprylate, glycerol monocaprate Tetraglycerinmonocaprat, Tetraglycerinmonolaurat, Pentaglycerinmonocaprylat, penta, Pentaglycerinmonolaurat, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, Hexaglycerinmonolaurat, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerin- monocaprylate, Decaglycerinmonocaprat, decaglyceryl monolaurate , Decaglycerin monomyristate, decaglycerol monoisostearate, decaglycerol monostearate, decaglycerol monooleate,

Decaglycerinmonohydroxystearat, Decaglycerindicaprylat, Decaglycerindicaprat, Decaglycerindilaurat, Decaglycerindimyristat, Decaglycerindiisostearat, Decaglycerindistearat, Decaglycerindioleat, deca glycerindihydroxystearat, Decaglycerintricaprylat, Decaglycerintricaprat, Decaglycerintrilaurat, deca trimyristate, glycerol trihydroxystearate Decaglycerintriisostearat, Decaglycerintristearat, Decaglycerintrioleat and deca.

Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the nonionic oil-in-water emulsifier in a total amount of 0.5 to 10 wt .-%, particularly preferably 1 to 4 wt .-% and most preferably 1 , 5 - 3 wt .-%, based on the total composition is included.

Water-in-oil emulsifiers

Cosmetic compositions preferred according to the invention which are formulated as an emulsion or stick preferably furthermore contain at least one nonionic water-in-oil emulsifier having an HLB value of greater than 1.0 and less than or equal to 7.0, selected from the mono- and diesters of ethylene glycol and the mono-, di-, tri- and tetra-esters of pentaerythritol with linear saturated fatty acids with 12-30, in particular 14-22 carbon atoms, which may be hydroxylated, as well as mixtures thereof, as consistency regulator and / or water binder. According to the invention, the mono- and diesters are preferred. According to the invention, preferred C ₁₂ -C ₃ o-fatty acid radicals are selected from lauric acid, myristic acid, palmitic acid, stearic acid, and behenic acid Arachinsäure- radicals; particularly preferred is the stearic acid residue. Nonionic water-in-oil emulsifiers which are particularly preferred according to the invention and have an HLB value greater than 1.0 and less than 7.0 are selected from pentaerythrityl monosteate, pentaerythrityl distearate, pentaerythrityl tristearate, pentaerythrityl tetrastearate, ethylene glycol monostearate, ethylene glycol distearate and mixtures thereof. Particularly preferred water-in-oil emulsifiers according to the invention having an HLB value greater than 1.0, and less than or equal to 7.0 are for For example, as commercial products Cutina ^® PES (INCI: Pentaerythrityl distearate), Cutina ^® AGS (INCI: Glycol distearate) or Cutina ^® EGMS (INCI: Glycol Stearate) available. These commercial products are already mixtures of mono- and diesters (in the pentaerythrityl esters are also tri- and tetraesters contain). According to the invention it may be preferred to use only a single water-in-oil emulsifier. In another preferred embodiment, the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two water-in-oil emulsifiers. A commercial product such as Cutina ^® PES is meant, for example, a technical mixture.

In addition to the stated water-in-oil emulsifiers based on the ethylene glycol or pentaerythrityl esters, in a preferred embodiment, at least one further nonionic water-in-oil emulsifier having an HLB value greater than 1, 0 and less than or equal to 7, 0 should be included, the proportion of the total weight of nonionic water-in-oil emulsifiers with an HLB value greater than 1, 0 and less than or equal to 7.0 preferably, but should not be greater than 80%. In a particularly preferred embodiment, the compositions according to the invention contain the at least one additional water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0 only in a proportion by weight of not more than 10% or are free of additional water in oil emulsifiers. Some of these additional suitable emulsifiers are listed, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology" 3rd Ed., 1979, Vol. 8, page 913. For ethoxylated adducts, the HLB value, as already mentioned, can also be calculated.

As water-in-oil emulsifier are preferably suitable:

linear saturated alkanols having 12-30 carbon atoms, in particular having 16-22 carbon atoms, in particular cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and lanolin alcohol or mixtures of these alcohols, as obtainable in the industrial hydrogenation of vegetable and animal fatty acids,

Esters and in particular partial esters of a polyol having 3 to 6 C atoms and linear saturated and unsaturated fatty acids having 12 to 30, in particular 14 to 22, C atoms which may be hydroxylated. Such esters or partial esters are, for. For example, the mono- and diesters of glycerol or monoesters of propylene glycol with linear saturated and unsaturated d ₂ - C ₃₀ carboxylic acids, which may be hydroxylated, in particular those with palmitic and stearic, the sorbitan mono-, -di- or triesters of linear saturated and unsaturated C ₁₂ -C ₃₀ carboxylic acids which may be hydroxylated, in particular those of myristic acid, palmitic acid, stearic acid or of mixtures of these fatty acids and the methyl glucose mono- and diesters of linear saturated and unsaturated C 12 -C ₃₀ - Carboxylic acids which may be hydroxylated;

Sterols, ie steroids which carry a hydroxyl group at the C3 atom of the steroid skeleton and both from animal tissue (zoosterols, eg cholesterol, lanosterol) as well as from plants (phytosterols, eg ergosterol, stigmasterol, sitosterol) and from mushrooms and yeasts (mycosterines) and which may be low ethoxylated (1-5 EO);

Alkanols and carboxylic acids each having 8-24 C atoms, in particular having 16-22 C atoms, in the alkyl group and 1-4 ethylene oxide units per molecule which have an HLB value of greater than 1.0, and less than or equal to 7.0 exhibit,

Glycerol monoethers of saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 8-30, in particular 12-18 carbon atoms.

Partial esters of polyglycerols with n = 2 to 10 glycerol units and with 1 to 5 saturated or unsaturated, linear or branched, optionally hydroxylated C ₈ - C ₃₀ fatty acid esters esterified, if they have an HLB value of less than or equal to 7,

and mixtures of the aforementioned substances.

According to the invention, it may be preferable to use only a single additional water-in-oil emulsifier. In another preferred embodiment, the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two additional water-in-oil emulsifiers. For example, a commercial product such as Cutina GMS ^® is understood to be a technical mixture, which is a mixture of glyceryl monostearate and glyceryl distearate.

Particularly advantageous additional water-in-oil emulsifiers are stearyl alcohol, cetyl alcohol, glyceryl monostearate, in particular in the form of the commercial products Cutina ^® GMS and Cutina ^® MD (ex Cognis), glyceryl distearate, glyceryl monocaprinate, glyceryl monocaprylate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monohydroxystearate , glyceryl monooleate, glyceryl rylmonolanolat, Glyceryldimyristat, Glyceryldipalmitat, glyceryl dioleate, propylene glycol monostearate, pro pylenglycolmonolaurat, sorbitan monopalmitate, sorbitan monolaurate, sorbitan monomyristate, sorbitan, sorbitan monostearate, tansesquioleat Sorbita nsesquistea rat, sorbitan distearate, sorbitan dioleate, sorbitan, sucrose distearate, arachidyl alcohol, behenyl alcohol, polyethylene glycol (2) stearyl ether (steareth-2), steareth-5, oleth-2, diglycerol monostearate, diglycerol monoisostearate, diglycerol monooleate, diglycerin dihydroxystearate, diglycerol distearate, diglycerol dioleate, triglycerol distea rat, tetraglycerol monostearate, tetraglycerol distearate, tetraglycerol tristearate, decaglycerol pentastearate, decaglycerol pentahydroxystearate, decaglycerol pentaisostearate, decaglycerol pentaoleate, soy sterol, PEG-1 soy sterol, PEG-5 soy sterol, PEG-2 monolaurate and PEG-2 monostearate.

Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one water-in-oil emulsifier is present in a total amount of 0.1-15% by weight, preferably 0.5-8.0% by weight, and particularly preferably 1 to 4 wt .-%, based on the total composition, are included. Furthermore, amounts of from 2 to 3% by weight, based on the total weight of the composition, according to the invention may also be extremely preferred. The HLB values can be calculated according to Griffin, as described, for example, in the RÖMPP Chemie Lexikon, in particular in the online version of November 2003, and there under the keyword "HLB system" cited manuals by Fiedler, Kirk-Othmer and Janistyn (H. Janistyn, Handbook of cosmetics and fragrances, Hüthig-Verlag Heidelberg, 3rd edition, 1978, Volume 1, page 470 and Volume 3, pages 68-78 If there is different information on the HLB value of a substance in the literature, the HLB value should be used for the teaching according to the invention which comes closest to the value calculated according to Griffin If no clear HLB value can be determined, the HLB value given by the manufacturer of the emulsifier must be used for the teaching according to the invention. If this too is not possible, the HLB value must be determined experimentally.

Further preferred cosmetic agents according to the invention are characterized in that the total content of nonionic and ionic emulsifiers and / or surfactants having an HLB value of more than 8 not more than 20 wt.%, Preferably not more than 15 wt.%, Particularly preferably not more than 10 wt. %, particularly preferably not more than 7% by weight, more preferably not more than 4% by weight and even more preferably not more than 3% by weight, based in each case on the total composition according to the invention.

Cosmetic agents which are particularly preferred according to the invention and which have been formulated as a water-in-oil emulsion preferably furthermore comprise at least one water-in-oil emulsifier. The at least one water-in-oil emulsifier is preferably in an amount of 0.5 to 5 wt .-%, particularly preferably 1, 0 to 1, 5 to 2.5 wt .-%, each based on the total weight of Emulsion, included.

A particularly preferred group of water-in-oil emulsifiers according to the invention are the poly (C ₂ -C ₃ ) alkylene glycol-modified silicones whose previous INCI name was Dimethicone Copolyol, with the current INCI names PEG-x Dimethicone (with x = 2-20, preferably 3-17, more preferably 1-1-12), bis-PEG-y dimethicones (with y = 3-25, preferably 4-20), PEG / PPG a / b dimethicones (where a and b independently of one another are numbers from 2 to 30, preferably 3 to 30 and particularly preferably 12 to 20, in particular 14 to 18,), bis-PEG / PPG-c / d dimethicones (where c and d independently of one another represent numbers of 10 25, preferably 14-20 and more preferably 14-16) and bis-PEG / PPG-e / f PEG / PPG g / h dimethicones (where e, f, g and h independently of one another represent numbers from 10 to 20) , preferably 14-18 and more preferably 16, stand). Particular preference is given to PEG / PPG-18/18 dimethicones, which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C, PEG / PPG-4/12 dimethicone, sold under the name Abil B 8852 is available as well as Bis-PEG / PPG-14/14 Dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt), Bis-PEG / PPG-20/20 Dimethicone, under the name Abil B 8832 is available, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 dimethicones (Silsoft 430 and Silsoft 440).

Further according to the invention preferred W / O emulsifiers are poly (C ₂ -C ₃₎ alkylene glycol-modified silicones, the ₄ -C ₈ alkyl groups are hydrophobically modified with C, more preferably cetyl PEG / PPG-10/1 Dimethicone (formerly Cetyl dimethicone copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, cetyl PEG / PPG-10/1 dimethicone and hexyl laurate under the trade name Abil WE 09), furthermore alkyl methicone copolyols.

Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance. Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate and 2-hydroxy-methyl-3 , 5.5-trimethylcyclohexanol. Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.

It is particularly preferred according to the invention for at least one skin-cooling active ingredient to be present in a total amount of 0.01-1% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2% by weight, in each case based on the total weight of the composition.

Cosmetic agents which are particularly preferred according to the invention and which are formulated as a propellant-driven aerosol contain at least one propellant. Preferred propellants (propellants) are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1-difluoroethane, both individually and in combination. Also hydrophilic propellants, such. As carbon dioxide, can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess. Particularly preferred are propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.

The amount of blowing agent is preferably 5-95% by weight, particularly preferably 20-88% by weight and very preferably 30-80% by weight, in each case based on the total weight of the preparation, consisting of the composition according to the invention (= inventive Mitel) and the propellant.

As pressure gas container come vessels made of metal (aluminum, tinplate, tin), protected or non-splitterndem plastic or glass, which is coated with plastic outside, in question, in their selection pressure and fracture resistance, corrosion resistance, easy fillability as well as aesthetic Aspects, handiness, printability etc. play a role. Special internal protective lacquers ensure corrosion resistance to the composition according to the invention. Preferred compositions according to the invention also comprise at least one water-soluble polyhydric C ₂ -C ₉ -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof. These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, pentylene glycols, such as 1,2-pentanediol and 1, 5-pentanediol, hexanediols such as 1, 2-hexanediol and 1, 6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, Erythritol, sorbitol, cis-1,4-dimethylolcyclohexane, trans-1,4-dimethylolcyclohexane, any isomeric mixtures of cis- and trans-1,4-dimethylolcyclohexane, as well as mixtures of the aforementioned substances. Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.

Preferred deodorant or antiperspirant compositions according to the invention comprise at least one water-soluble polyhydric C ₂ -C ₉ -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units, which is selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1,5-pentanediol, hexanediols as 1, 2- Hexanediol and 1,6-hexanediol, hexanetriols such as 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol, cis-1, 4-dimethylol cyclohexane, trans-1, 4-dimethylolcyclohexane, any isomeric mixtures of cis- and trans-1, 4-dimethylolcyclohexane and mixtures of the abovementioned substances.

Particularly preferred deodorant or antiperspirant compositions according to the invention comprise at least one water-soluble polyhydric C ₂ -C ₉ -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units in a total amount of 3 to 30% by weight. %, preferably 8 to 25 wt .-%, particularly preferably 10 to 18 wt .-%, is contained, in each case based on the total weight of the composition, without taking into account any existing blowing agent.

Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one lipid or wax component having a melting point in the range of 25-50 ° C selected from coconut fatty acid glycerol mono-, di- and triesters, Butyrospermum Parkii (Shea Butter ) and esters of saturated, monohydric C ₈ -C ₈ alcohols with saturated C ₂ -C ₈ monocarboxylic acids and mixtures of these substances, is contained. These lower melting lipid or wax components allow consistency optimization of stick or cream products and minimization of visible residue on the stick Skin. Especially preferred are products sold under the INCI name Cocoglycerides, in particular the commercial products Novata ^® (ex Cognis), particularly preferably Novata AB ^®, a mixture of C ₂ -C ₈ mono-, di- and triglycerides, which is in the range of 30 - 32 ° C, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142. Further preferred esters of saturated, monovalent Ci ₂ -Ci ₈ - alcohols with saturated C ₂ -C ₈ monocarboxylic acids are stearyl laurate, cetearyl (z. B. Crodamol ^® CSS), cetyl palmitate (z. B. Cutina ^® CP) and myristyl myristate (z. B. Cetiol ^® MM).

Further particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one lipid or wax component having a melting point in the range from 25 to 50 ° C. in amounts of from 0.01 to 20% by weight is preferred From 3 to 20% by weight, more preferably from 5 to 18% by weight, and most preferably from 6 to 15% by weight, based on the total composition.

Particularly preferred deodorant or antiperspirant compositions according to the invention furthermore contain at least one solid, water-insoluble particulate filler in order to strengthen the consistency and to improve the sensory properties. In a highly preferred embodiment of this filler is selected from optionally modified starches (for. Example, of corn, rice, potatoes) and starch derivatives, which are, if desired, pregelatinized, in particular starch derivatives of type DRY FLO ^®, cellulose and cellulose derivatives, silica, silicic acids, e.g. , As Aerosil ^® types, spherical Polyalkylsesquisiloxan particles (especially Aerosil ^® R972 and Aerosil ^® 200V from Degussa), silica gels, talc, kaolin, clays, z. Bentonites, magnesium aluminum silicates, boron nitride, lactoglobulin derivatives, e.g. B. sodium C ₈ . ₁₆ - Isoalkylsuccinyllactoglobulinsulfonat from Brooks Industries available as a commercial product Biopol ^® OE, glass powders, polymer powders, in particular of polyolefins, polycarbonates, polyurethanes, polyamides, z. As nylon, polyesters, polystyrenes, polyacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers which may be crosslinked, or silicones, and mixtures of these substances. Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ^® 6603 (Dow Corning) available. Other polymer powders, e.g. Example based on polyamides, obtainable under the name Orgasol ^® 1002 (polyamide-6) and Orgasol ^® 2002 (polyamide-12) from Elf Atochem. Other polymer powders which are suitable for the purpose according to the invention are, for. B. polymethacrylates (Micro Pearl ^® M from SEPPIC or Plastic Powder A of NIKKOL), styrene-divinylbenzene copolymer (Plastic Powder FP of NIKKOL), polyethylene and polypropylene powder ^(® ACCUREL EP 400 from AKZO), or silicone polymers (Silicone Powder X2-1605 from Dow Corning). Particularly preferred deodorant or antiperspirant compositions according to the invention comprise at least one solid, water-insoluble particulate filler in a total amount of from 0.01 to 30% by weight, preferably from 5 to 20% by weight, particularly preferably from 8 to 15% by weight, in each case based on the total composition.

Particularly preferred deodorant or antiperspirant compositions according to the invention also contain at least one perfume. The definition of a fragrance in the sense of the present application is in accordance with the expert definition as it can be found in the RÖMPP Chemie Lexikon, as of December 2007. Thereafter, a fragrance is a chemical compound with smell and / or taste that excites the hair cell receptors (adequate stimulus). The necessary physical and chemical properties are a low molecular weight of at most 300 g / mol, a high vapor pressure, minimal water and high lipid solubility and weak polarity and the presence of at least one osmophoric group in the molecule. In order to delineate volatile, low molecular weight substances which are usually and also not regarded as perfuming agents, but primarily as solvents, such as, for example, ethanol, propanol, isopropanol and acetone, odorants according to the invention, fragrances according to the invention have a molecular weight of 74 to 300 g / mol, contain at least one osmophoric group in the molecule and have an odor and / or taste, that is, they excite the receptors of the hair cells of the olfactory system.

As perfumes, perfumes, perfume oils or perfume oil ingredients can be used. Perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are known e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate. The ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g. the linear alkanals of 8 - 18 C atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g. the ionones, alpha-lsomethylionone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance.

Particularly preferred deodorant or antiperspirant compositions according to the invention comprise at least one perfume component in a total amount of 0.00001 to 10% by weight, preferably 0.5 to 5% by weight. %, most preferably 1 to 4 wt .-%, in each case based on the total weight of the composition, without taking into account any existing blowing agent.

The composition of some preferred cosmetic agents can be found in the following tables (data in% by weight based on the total weight of the cosmetic agent, unless stated otherwise).

Formula 1 Formula 2 Formula 3 Formula 4 Formula 5

Bactericidal A 0.1 to 1.0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Fragrance ester B 0.1 to 1.0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Mise add 100 add 100 add 100 add 100 add 100

Formula 6 Formula 7 Formula 8 Formula 9 Formula 10

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Perfume ester B 0.1 to 1.0, 0.2 to 0 , 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Mise add 100 add 100 add 100 add 100 add 100

Formula 1 1 Formula 12 Formula 13 Formula 14 Formula 15

Bactericidal A 0.1 to 1.0, 0.2 to 0.9 0.3 to 0.8, 0.4 to 0.7, 0.4 to 0.7

Menthyl acetate 0, 1 to 1, 0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Mise add 100 add 100 add 100 add 100 add 100

Formula 16 Formula 17 Formula 18 Formula 19 Formula 20

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7

Menthyl acetate 0, 1 to 1, 0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Mise add 100 add 100 add 100 add 100 add 100

Formula 21 Formula 22 Formula 23 Formula 24 Formula 25

Bactericidal A 0.1 to 1.0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Fragrance ester B 0.1 to 1.0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Antiperspirant 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25 active ingredient c)

Mise add 100 add 100 add 100 add 100 add 100

Formula 26 Formula 27 Formula 28 Formula 29 Formula 30

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Perfume ester B 0.1 to 1.0 O 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Antiperspirant 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25 active ingredient c)

Mise add 100 add 100 add 100 add 100 add 100

Formula 31 Formula 32 Formula 33 Formula 34 Formula 35

Bactericidal A 0.1 to 1.0, 0.2 to 0.9 0.3 to 0.8, 0.4 to 0.7, 0.4 to 0.7

Menthyl acetate 0, 1 to 1, 0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Antiperspirant 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25

Active ingredient c)

Mise add 100 add 100 add 100 add 100 add 100

Formula 36 Formula 37 Formula 38 Formula 39 Formula 40

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7

Menthyl acetate 0, 1 to 1, 0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Antiperspirant 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25

Active ingredient c)

Mise add 100 add 100 add 100 add 100 add 100

Formula 41 Formula 42 Formula 43 Formula 44 Formula 45

Bactericidal A 0.1 to 1.0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Fragrance ester B 0.1 to 1.0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Aluminum chlorohydrate 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25 Mise add 100 add 100 add 100 add 100 add 100

Formula 46 Formula 27 Formula 48 Formula 49 Formula 50

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Perfume ester B 0.1 to 1.0, 0.2 to 0 , 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Aluminum chlorohydrate 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25 Mise add 100 add 100 add 100 add 100 add 100

Formula 51 Formula 32 Formula 53 Formula 54 Formula 55

Bactericidal A 0.1 to 1.0, 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Menthyl acetate 0, 1 to 1, 0 0.2 to 0 , 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Aluminum chlorohydrate 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25 Mise add 100 add 100 add 100 add 100 add 100 Formula 56 Formula 57 Formula 58 Formula 59 Formula 60

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 menthyl acetate 0, 1 to 1, 0 0.2 to 0, 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5 Aluminum chlorohydrate 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25 Mise add 100 add 100 add 100 add 100 add 100

Formula 61 Formula 62 Formula 63 Formula 64 Formula 65

Bactericidal A 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Fragrance ester B 0, 1 to 1, 0 0.2 to 0.8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Al-Zr-tetrachlorohydrex Gly 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25

Mise add 100 add 100 add 100 add 100 add 100

Formula 66 Formula 67 Formula 68 Formula 69 Formula 70

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Perfume ester B 0, 1 to 1, 0 0.2 to 0 , 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Al-Zr-tetrachlorohydrex Gly 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25

Mise add 100 add 100 add 100 add 100 add 100

Formula 71 Formula 72 Formula 73 Formula 74 Formula 75

Bactericidal A 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 Menthyl acetate 0.1 to 1, 0 0.2 to 0 , 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Al-Zr-tetrachlorohydrex Gly 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25

Mise add 100 add 100 add 100 add 100 add 100

Formula 76 Formula 77 Formula 78 Formula 79 Formula 80

Phenoxyethanol 0, 1 to 1, 0 0.2 to 0.9 0.3 to 0.8 0.4 to 0.7 0.4 to 0.7 menthyl acetate 0.1 to 1, 0.2 to 0, 8 0.3 to 0.6 0.3 to 0.6 0.3 to 0.5

Al-Zr-tetrachlorohydrex Gly 5 to 50 10 to 30 10 to 30 15 to 25 15 to 25

Mise add 100 add 100 add 100 add 100 add 100

As stated above, the cosmetic compositions of the invention are characterized by a long-lasting deodorizing effect. Another object of the present invention is a method for the treatment of body odor, characterized in that a cosmetic agent according to the invention is applied to the skin. Claimed is still the Use of a cosmetic agent according to the invention for the non-therapeutic treatment of body odor.

Also with regard to preferred embodiments of the inventive use and the method according to the invention mutatis mutandis applies to the means of the invention.

Claims

Patent claims

1. Cosmetic composition contained in a cosmetically acceptable carrier

a) 0.1 to 1.0% by weight of at least one nonionic bactericide A with a boiling point above 120 ° C

b) 0.1 to 1.0% by weight of at least one fragrance ester B.

2. Cosmetic agent according to claim 1, characterized in that the agent, based on its total weight, 0.2 to 0.9% by weight, preferably 0.3 to 0.8% by weight and in particular 0.4 to Contains 0.7% by weight of bactericide A.

3. Cosmetic agent according to one of the preceding claims, characterized in that at least one bactericide from the group of chlorhexidine, farnesol, trichlosan, chloroxylenol and phenoxyethanol, preferably phenoxyethanol, is contained as bactericide A.

4. Cosmetic agent according to one of the preceding claims, characterized in that the agent, based on its total weight, 0.1 to 0.8% by weight, preferably 0.2 to 0.6% by weight and in particular 0. Contains 3 to 0.5% by weight of fragrance ester B.

5. Cosmetic agent according to one of the preceding claims, characterized in that the fragrance ester B is at least one fragrance ester from the group 3a, 4, 5, 6, 7, 7a-hexahydro-4,7-methano-1 H-indenyl acetate, tricyclo[ 5.2.1 .02,6]dec-4-en-8-yl acetate, 3a,4,5,6,7,7a-hexahydro-4,7-methanoinden-6-yl acetate, 2-tert-butylcyclo- hexyl acetate, cis-2-tert-butylcyclohexyl acetate, trans-2-tert-butylcyclohexyl acetate, 4-tert-butylcyclohexyl acetate, cis-4-tert-butylcyclohexyl acetate, trans-4-tert-butylcyclohexyl acetate, 3a,4,5,6,7, 7a-Hexahydro-4,7-methano-1 H-indenyl propionate, 3a,4,5,6,7,7a-Hexahydro-4,7-methano-1 H-inden-6-yl propionate, 3a,4, 5,6,7,7a-Hexahydro-4,7-methano-1 H-inden-5-yl propionate, benzyl salicylate, cyclohexyl salicylate, pentyl salicylate, 2-methylbutyl salicylate, isopentyl salicylate, exo-1,7,7-trimethylbicyclo[2.2. 1]hept-2-yl acetate, p-menth-1-en-8-yl acetate, terpineol acetate, benzyl acetate, hexyl salicylate, alpha, alpha-dimethytphenethyl acetate, 1-phenylethyl acetate, linalyl acetate, phenethyl acetate, hexyl acetate, citronellyl acetate, geranyl acetate, neryl acetate, Citronellyl acetate, p-menthan-8-yl acetate, alpha, alpha- 4-trimethylcyclohexylmethyl acetate, nopyl acetate, ethyl acetoacetate, 3-methyl-2-butenyl acetate, 2-cyclohexyl ethyl acetate, isononyl acetate, isobutyl salicylate, [3R-(3. alpha. ,3a. beta. ,7. beta. ,8a. alpha. )]- 2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-1H-3a,7-methanoazulene-6-methylacetate,

Phenethylphenyl acetate, (Z)-3-hexenyl salicylate, (Z)-hex-3-enyl acetate, 1,3-dimethyl-3-phenylbutyl acetate, methyl salicylate, isopentyl acetate, neryl acetate, cinnamyl acetate, menthyl acetate, 1,2,3,3a,4,5,6,8a-Octahydro-2-isopropylidene-4,8-dimethylazulen-6-yl acetate, allylphenoxyacetate, decahydro-2-naphthyl acetate, myrcenyl acetate, methyl phenyl acetate, ethyl salicylate, 3(or 4)-(4-Methylpenten-3-yl)cyclohex-3-ene-1-methylacetate, 1-methyl-1-((3S,8S)-1, 2,3,4, 5,6,7,8 -octahydro-3,8-dimethy)azuten-5-yl)ethyl acetate, ethyl acetate, phenyl salicylate, phenethyl salicylate, p-tolyl acetate, p-tolylphenyl acetate and/or 1, 1,5-trimethylhepta-4,6-dienyl acetate, preferably menthyl acetate, is included.

6. Cosmetic agent according to one of the preceding claims, characterized in that the agent further contains at least one antiperspirant active ingredient c), preferably an antiperspirant active ingredient c) from the group of water-soluble astringent inorganic and organic salts of aluminum and zinc, in particular from the group of contains activated aluminum salts.

7. Cosmetic agent according to one of the preceding claims, characterized in that the cosmetic agent, based on its total weight, contains 5 to 50% by weight, preferably 10 to 30% by weight and in particular 15 to 25% by weight of the antiperspirant Active ingredient c) contains.

8. Cosmetic agent according to one of the preceding claims, characterized in that the cosmetic agent contains an ester d) of a C ₃ -C ₃₀ carboxylic acid, preferably an ester d) from the group 2-ethylhexyl palmitate, isopropyl palmitate and triethyl citrate.

9 Cosmetic agent according to one of the preceding claims, characterized in that the cosmetic agent is a nonionic surfactant e) from the group of polyalkylene glycol ethers, preferably from the group of alkoxylated C ₈ -C ₂ 4-alkanols with an average of 10 - 100 moles of alkylene oxide per mole , preferably from the group of ethoxylated Ci ₂ -Ci ₈ alkanols with an average of 10 - 30 moles of ethylene oxide per mole.

10. Use of a cosmetic agent according to one of claims 1 to 9 for the treatment of body odor.